Speaker Details

Laura K. Ferris, MD, PhD, FAAD

Laura K. Ferris, MD, PhD, FAAD

SESSIONS

S026 Late-breaking Research: Session 1
Mar 9, 2024 • 9:00 AM - 12:00 AM • Room 20B
F065 What's New in the Management of Advanced Skin Cancer
Mar 9, 2024 • 3:30 PM - 12:00 AM • Room 31B
F076 Melanoma in Situ: Ongoing Controversies and New Insights
Mar 10, 2024 • 3:30 PM - 12:00 AM • Room 11B

DISCLOSURES

AbbVie – Consultant(Honoraria), Investigator(Other Financial Benefit); Almirall – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Other Financial Benefit); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Other Financial Benefit), Speaker(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Consultant(Honoraria); Castle Biosciences, Inc – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Janssen Research & Development, LLC – Investigator(Other Financial Benefit); Novartis – Investigator(Other Financial Benefit); Pfizer Inc. – Data Safety Monitoring Board(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Other Financial Benefit); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);